Lombard Odier Asset Management (Switzerland)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-413,115
Closed -$10.1M 397
2023
Q1
$10.1M Buy
413,115
+177,556
+75% +$3.89M 0.88% 33
2022
Q4
$5.04M Buy
235,559
+173,942
+282% +$3.71M 0.4% 63
2022
Q3
$1.1M Buy
+61,617
New +$809K 0.09% 149

Other funds holding ISEE

Lombard Odier Asset Management (Switzerland)'s ISEE Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 413,115 shares — an estimated $10.1M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in ISEE in Q3 2022 and held it in 3 quarters. The position peaked at $10.1M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 413,115 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $10.1M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Lombard Odier Asset Management (Switzerland)'s IVERIC bio, Inc. Common Stock position peaked at $10.1M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.